Supplementary Table 3.docx (22.78 kB)

Supplementary Table 3. Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort

dataset

posted on 2021-05-20, 08:28 authored by Jean-Philippe Metges, Dominique Genet, David Tougeron, Catherine Ligeza, Michel Ducreux, Christophe Borg, Rosine Guimbaud, Jean-Marc Phelip, Louis-Marie Dourthe, Stefano Kim

Supplementary Table 3. Patient demographics and baseline characteristics in the French cohort of the CORRELATE study, stratified by ECOG PS.

Funding

Bayer

History

Usage metrics

Future Oncology

Keywords

colorectal cancer CORRELATE metastatic multi-kinase inhibitor regorafenib Solid Tumours

Licence

CC BY-NC-ND 4.0